Gemcitabine + Nab-paclitaxel

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid TumorsNCT07020221VSTMPhase 1, Phase 2Recruiting2028-12Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.